Artemis Medicare Services shares rose 6.45% to close at ₹354.25 from the previous close of ₹332.8, demonstrating continued momentum in Friday's trading session. According to latest market data, the stock opened at ₹342.7, touched a high of ₹358, and recorded a low of ₹342.7 during the session. The stock traded within a range of ₹342.7 to ₹358 with a turnover of ₹0.19 crore. The company's market capitalisation now stands at ₹5,414.07 crore, placing the move in a clearly defined market-cap context and reinforcing its position in the healthcare sector.
The stock has shown remarkable resilience with a 87% bounce from its 52-week low of ₹202.85 touched on April 13, 2026. As reported by Business Standard, at 11:38 AM, Artemis Medicare Services quoted 10% higher at ₹365.55, compared to a 0.17% decline in the BSE Sensex. A combined 12.75 million equity shares representing 8% of total equity changed hands on the NSE and BSE during the trading session, indicating strong investor interest in the healthcare sector.
According to Business Standard, Artemis Medicare Services operates 800+ beds predominantly in the Delhi NCR region, including a 700+ bed quaternary care, super speciality hospital accredited by JCI (Joint Commission International) and NABH (National Accreditation Board for Hospitals & Healthcare Providers). The company runs a joint venture with Philips under the Artemis Cardiac Care brand and has overseas presence in Mauritius through an operations and management arrangement. An important milestone was the commencement of operations at its Raipur hospital in July 2026, marking significant expansion into high-growth markets.
As reported by Business Standard, the company's flagship Gurugram hospital continued to perform well, supported by improved occupancy, higher average revenue per occupied bed (ARPOB), and sustained demand across specialized clinical services. The management noted that international patient business also continued to perform well during the quarter despite the West Asian war, with demand from Middle East, Africa, CIS, and other international markets supported by strong clinical outcomes and patient experience.
According to latest market data, Artemis Medicare Services trades with a P/E ratio of 46.36x, which is close to the same-industry median of 47.11x, representing a difference of -1.59%. The P/B ratio stands at 5.87x, above the median of 3.88x, while the company maintains strong profitability metrics with ROE of 12.72% and ROCE of 15.83%. Key financial metrics include EPS of ₹7.18, book value per share of ₹56.68, and dividend yield of 0.14%. The company operates in the Healthcare sector and Hospital & Healthcare Services industry with a market capitalisation of ₹5,414.07 crore, placing it in the Mid Cap category.
